The global 3D bioprinted human tissue market size was valued at USD 2.3 billion in 2024, driven by growing investments in biotechnology research and development across the globe. The market is expected to grow at a CAGR of 8.4% during the forecast period of 2025-2034, with the values likely to rise from USD 2.5 billion in 2025 to USD 4.8 billion by 2034. This remarkable growth is primarily...

"Executive Summary Pingueculum Drugs Market : CAGR Value :  Data Bridge Market Research analyses that the global pingueculum drugs market will grow at a CAGR of 7.3% during the forecast period of 2022 to 2029.   All statistical and numerical data is interpreted with the use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis. Few of the...

The advancement of trispecific antibodies is opening new doors in the field of cancer treatment. Unlike traditional monoclonal or bispecific antibodies, these novel agents are capable of engaging three distinct targets, which enhances immune cell activation and tumor cell recognition. As a result, trispecifics offer the potential for greater therapeutic precision and improved clinical...

Inside every cell, complex communication networks are constantly at work. These systems—known as signaling pathways—allow cells to respond to changes in their environment, control growth, defend against threats, and carry out essential biological tasks. One of the key methods cells use to transmit signals is phosphorylation, a process where a phosphate group is added to a protein to...

  The AACR Annual Meeting 2025 is a globally recognized event that brings together leading experts, researchers, and healthcare professionals to share groundbreaking discoveries in cancer research. As one of the most anticipated conferences in oncology, it provides a platform for unveiling the latest advancements in cancer treatments, diagnostics, and cutting-edge therapies. Attendees will...

Ace Therapeutics, a premier preclinical CRO, announces its dedicated preclinical ophthalmic drug development services to help expedite the discovery and development of cutting-edge treatments for ocular diseases. At the core of innovation and compliance is Ace Therapeutics, which assists pharma and biotech firms to launch successful ophthalmic therapies. The development of drugs for the...

The landscape of Duchenne Muscular Dystrophy management is experiencing unprecedented transformation as researchers translate decades of basic science discoveries into innovative therapeutic interventions. This X-linked genetic disorder affects approximately 300,000 boys and young men globally, representing the most common fatal inherited disease of childhood. The absence of functional...

    In recent years, the fight against cancer has seen significant advances, particularly with the emergence of targeted therapy. Among the most promising strategies in this domain is the development of radioactive drug conjugates(RDCs). These innovative therapeutic agents combine the targeting capabilities of antibodies with the cytotoxic effects of radioactive isotopes, providing a...

    Traumatic Brain Injury (TBI) remains a pressing global health concern, affecting individuals across all age groups. The Traumatic Brain Injury Market: Insights, Trends, and Future Outlook by DelveInsight delves into current therapeutic strategies, emerging drug developments, and the future of TBI treatment. With increasing research, investment, and awareness, the TBI market is...

Artificial intelligence (AI) is transforming the biopharma industry by accelerating drug discovery, optimizing clinical trials, and enhancing patient outcomes. As AI technologies evolve, their integration into biopharma operations is breaking long-standing barriers, yet it also presents new challenges that require careful navigation. Understanding the dynamic relationship between AI and the...